SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001214659-23-002280
Filing Date
2023-02-14
Accepted
2023-02-14 14:23:26
Documents
1
Group Members
CHEN YUTCG CROSSOVER FUND I, L.P.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 cyma213230sc13ga1.htm SC 13G/A 82066
  Complete submission text file 0001214659-23-002280.txt   83816
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Subject) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87950 | Film No.: 23627110
SIC: 2834 Pharmaceutical Preparations

Mailing Address 228 HAMILTON AVENUE, 3RD FLOOR PALO ALTO CA 94301
Business Address 228 HAMILTON AVENUE, 3RD FLOOR PALO ALTO CA 94301 650-798-5495
TCG Crossover GP I, LLC (Filed by) CIK: 0001839947 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A